FIELD: pharmaceutics.
SUBSTANCE: invention relates to use of 1'-(1-methoxyphenyl)dispiro[cyclohexane-1,3'-azetidine-2',3''-indoline]-2'',4'-dione of formula (1), as a cytotoxic drug means.
EFFECT: use of 1'-(1-methoxyphenyl)dispiro[cyclohexane-1,3'-azetidine-2',3''-indoline]-2'',4'-dione 1, having moderate cytotoxicity towards HEK 293 cells (human embryonic kidney cells).
1 cl, 1 tbl, 2 ex
(1)
Title | Year | Author | Number |
---|---|---|---|
USE OF 1'-ARYLDISPIRO[CYCLOALKANE-1,3'-AZETIDINE-2',3''-INDOLINE]-2'',4'-DIONES AS ANALGESICS | 2023 |
|
RU2809008C1 |
NEW DISPIRO-INDOLINONES, MDM2/p53 INTERACTION INHIBITORS, METHOD FOR PRODUCTION AND APPLICATION | 2015 |
|
RU2629750C2 |
MDM2 PROTEIN DESTRUCTORS | 2017 |
|
RU2743432C2 |
METHOD FOR THE PREPARATION OF 1-(2-PROPARGYL)-1H-NAPHTHO[2,3-d][1,2,3]TRIAZOLE-4,9-DIONE-4-OXIME-2-OXIDE | 2022 |
|
RU2791249C1 |
4-(2,4-DIMETHOXYPHENYL)-2-(2-HYDROXYPHENYL)-5,6-DIHYDRO-4N-BENZO[H]CHROMENE-3-CARBOXYLIC ACID, HAVING CYTOTOXIC ACTIVITY | 2019 |
|
RU2707972C1 |
CRYSTALS OF DIPYROPYRROLIDINE DERIVATIVES | 2013 |
|
RU2647840C2 |
METHOD OF OBTAINING DISPIROINDOLINONES | 2018 |
|
RU2682678C1 |
DISPIROINDOLINONES BASED ON RHODANINES AS P53-MDM2 INHIBITORS OF PROTEIN-PROTEIN INTERACTION | 2019 |
|
RU2730286C1 |
2-AMINO-1-BENZAMIDO-5-[2-(NAPHTHALENE-1-YL)-2-OXOETHYLIDENE]-4-OXO-4,5-DIHYDRO-1H-PYRROLE-3-CARBOXAMIDE EXHIBITING CYTOTOXIC AND PROAPOPTOGENIC PROPERTIES AGAINST HUMAN SOLID TUMOUR CELLS, INCLUDING THOSE RESISTANT TO CHEMOTHERAPEUTIC AGENTS | 2020 |
|
RU2753479C1 |
AGENT POSSESSING CYTOTOXIC ACTIVITY | 2019 |
|
RU2714932C1 |
Authors
Dates
2024-12-03—Published
2024-04-08—Filed